Matches in SemOpenAlex for { <https://semopenalex.org/work/W3185021083> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W3185021083 endingPage "32" @default.
- W3185021083 startingPage "17" @default.
- W3185021083 abstract "Objective To evaluate the cost-effectiveness of paliperidone palmitate (paliperidone long-acting injectable; PP) compared with long-acting injectable risperidone (RRP) in multi-episode patients (two or more relapses) with schizophrenia in Italy. Methods A pre-existing Markov model was utilized to simulate the history of a cohort of multi-episode patients transitioning through different health states on a monthly basis over a 12 or 24 month horizon from the perspective of the Italian National Health Service. Therapeutic strategies consisted of treatment with long-acting injectable risperidone (mean dose 37.5 mg every 2 weeks) or paliperidone palmitate (mean dose 75 mg equivalent [eq.] every month). Probability of relapse, level of adherence, side effects (extrapyramidal symptoms, tardive dyskinesia, weight gain and diabetes) and treatment discontinuation (switch) were derived from long-term observational data when feasible. The cost-effectiveness analysis considered quality adjusted life-years (QALYs) and direct medical costs. QALYs and costs (expressed in 2014 euro) were discounted at 3% annually. A one-way sensitivity analysis and a probabilistic sensitivity analysis were conducted. Results Paliperidone palmitate is the dominant long-acting injectable therapeutic option: a more effective (additional QALYs, less relapses) and less costly treatment option compared with long-acting injectable risperidone over a 12 or 24 month horizon. Results were robust when tested in sensitivity and probabilistic analyses. Conclusions Paliperidone palmitate was cost-saving from the Italian National Health Service perspective compared with long-acting injectable risperidone in the long-term treatment of multi-episode (two or more relapses) schizophrenia patients." @default.
- W3185021083 created "2021-08-02" @default.
- W3185021083 creator A5028106596 @default.
- W3185021083 creator A5034549425 @default.
- W3185021083 creator A5063212886 @default.
- W3185021083 date "2014-12-18" @default.
- W3185021083 modified "2023-10-18" @default.
- W3185021083 title "Cost-effectiveness analysis of paliperidone palmitate versus long-acting risperidone as maintenance treatment in schizophrenia patients in Italy" @default.
- W3185021083 doi "https://doi.org/10.33393/grhta.2015.321" @default.
- W3185021083 hasPublicationYear "2014" @default.
- W3185021083 type Work @default.
- W3185021083 sameAs 3185021083 @default.
- W3185021083 citedByCount "0" @default.
- W3185021083 crossrefType "journal-article" @default.
- W3185021083 hasAuthorship W3185021083A5028106596 @default.
- W3185021083 hasAuthorship W3185021083A5034549425 @default.
- W3185021083 hasAuthorship W3185021083A5063212886 @default.
- W3185021083 hasBestOaLocation W31850210831 @default.
- W3185021083 hasConcept C112930515 @default.
- W3185021083 hasConcept C118552586 @default.
- W3185021083 hasConcept C184834754 @default.
- W3185021083 hasConcept C187212893 @default.
- W3185021083 hasConcept C2776412080 @default.
- W3185021083 hasConcept C2777126507 @default.
- W3185021083 hasConcept C2778715236 @default.
- W3185021083 hasConcept C2780057945 @default.
- W3185021083 hasConcept C2780494398 @default.
- W3185021083 hasConcept C2780616385 @default.
- W3185021083 hasConcept C2908997079 @default.
- W3185021083 hasConcept C3019080777 @default.
- W3185021083 hasConcept C71924100 @default.
- W3185021083 hasConceptScore W3185021083C112930515 @default.
- W3185021083 hasConceptScore W3185021083C118552586 @default.
- W3185021083 hasConceptScore W3185021083C184834754 @default.
- W3185021083 hasConceptScore W3185021083C187212893 @default.
- W3185021083 hasConceptScore W3185021083C2776412080 @default.
- W3185021083 hasConceptScore W3185021083C2777126507 @default.
- W3185021083 hasConceptScore W3185021083C2778715236 @default.
- W3185021083 hasConceptScore W3185021083C2780057945 @default.
- W3185021083 hasConceptScore W3185021083C2780494398 @default.
- W3185021083 hasConceptScore W3185021083C2780616385 @default.
- W3185021083 hasConceptScore W3185021083C2908997079 @default.
- W3185021083 hasConceptScore W3185021083C3019080777 @default.
- W3185021083 hasConceptScore W3185021083C71924100 @default.
- W3185021083 hasIssue "1" @default.
- W3185021083 hasLocation W31850210831 @default.
- W3185021083 hasOpenAccess W3185021083 @default.
- W3185021083 hasPrimaryLocation W31850210831 @default.
- W3185021083 hasRelatedWork W1810094402 @default.
- W3185021083 hasRelatedWork W2098826988 @default.
- W3185021083 hasRelatedWork W2276191468 @default.
- W3185021083 hasRelatedWork W2366013553 @default.
- W3185021083 hasRelatedWork W2950034398 @default.
- W3185021083 hasRelatedWork W3120303634 @default.
- W3185021083 hasRelatedWork W3125393953 @default.
- W3185021083 hasRelatedWork W4213049891 @default.
- W3185021083 hasRelatedWork W4281797775 @default.
- W3185021083 hasRelatedWork W2184537739 @default.
- W3185021083 hasVolume "2" @default.
- W3185021083 isParatext "false" @default.
- W3185021083 isRetracted "false" @default.
- W3185021083 magId "3185021083" @default.
- W3185021083 workType "article" @default.